Retatrutide 20mg Vial
£60.00
3 for £150
Storage Instructions
Store at -20°C. Protect from light. Reconstituted solutions should be refrigerated at 2–8°C and used within 14 days.
Description
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This triagonist architecture represents a distinct pharmacological approach in metabolic signalling research, engaging three incretin-related receptor pathways in preclinical models.
Research Context
Preclinical studies have examined Retatrutide's binding profiles across GIP, GLP-1, and glucagon receptors, investigating downstream signalling cascades and their interactions in metabolic pathway research. Supplied exclusively for in vitro laboratory research purposes.
Related Products
This product is supplied for in-vitro laboratory research only. Not for human consumption, medical treatment, or cosmetic use.